CHARACTERIZATION OF CCKB RECEPTORS ON GH(3) PITUITARY-CELLS - RECEPTOR ACTIVATION IS LINKED TO CA2+ MOBILIZATION

被引:7
作者
SMITH, AJ
PATEL, S
FREEDMAN, SB
机构
[1] Merck, Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex CM20 2QR, Terlings Park, Eastwick Road
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1994年 / 267卷 / 02期
关键词
CCKB RECEPTOR; GH(3) CELLS; PITUITARY; FUNCTIONAL COUPLING; G-PROTEIN; CA2+ MOBILIZATION; L-365,260;
D O I
10.1016/0922-4106(94)90173-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cholecystokinin receptors on GH(3) rat anterior pituitary cells have been characterised using radioligand binding and Ca2+ mobilisation. [I-125]Bolton Hunter CCK-8s (BHCCK) bound dose dependently to GH(3) cells (K-d 85 pM, B-max 23 fmol/mg protein). Competition curves with CCK-8s (IC50 2.4 nM), pentagastrin (IC50 45 nM), L-365,260 (IC50 25 nM) and devazepide (IC50 820 nM), were consistent with a population predominantly of CCKB receptors. Binding of [I-125]BHCCK to lysed cells was inhibited by 10 mu M GTP-gamma-S and 10 mu M GppNHp, suggesting the receptor was linked to a guanine nucleotide binding protein. Intracellular Ca2+ mobilisation was a functional consequence of CCKB receptor activation in GH(3) cells using the fluorescent dye fura-2. CCK-8s (0.1 nM-1 mu M) and the selective CCKB receptor agonist, pentagastrin, (0.1 nM-100 mu M) dose dependently increased intracellular Ca2+ with a similar maximal increase of 2.85-fold and 2.77-fold respectively. Response to a submaximal dose of the CCKB receptor agonist pentagastrin (100 nM) was dose dependently blocked by the CCKB receptor antagonist L-365,260. GH(3) cells may therefore provide a useful model to study CCKB receptor coupling in a pituitary cell line.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 37 条
  • [11] RECEPTORS FOR CHOLECYSTOKININ AND GASTRIN PEPTIDES DISPLAY SPECIFIC BINDING-PROPERTIES AND ARE STRUCTURALLY DIFFERENT IN GUINEA-PIG AND DOG PANCREAS
    FOURMY, D
    ZAHIDI, A
    FABRE, R
    GUIDET, M
    PRADAYROL, L
    RIBET, A
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 165 (03): : 683 - 692
  • [12] GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
  • [13] SOLUBILIZATION AND CHARACTERIZATION OF THE CHOLECYSTOKININ-B BINDING-SITE FROM PIG CEREBRAL-CORTEX
    GUT, SH
    DEMOLIOUMASON, CD
    HUNTER, JC
    HUGHES, J
    BARNARD, EA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (4-5): : 339 - 346
  • [14] HILL DR, 1987, J NEUROSCI, V7, P2967
  • [15] DISTINCT CHOLECYSTOKININ RECEPTORS IN BRAIN AND PANCREAS
    INNIS, RB
    SNYDER, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (11): : 6917 - 6921
  • [16] CHOLECYSTOKININ OCTAPEPTIDE-LIKE IMMUNOREACTIVITY - HISTOCHEMICAL LOCALIZATION IN RAT-BRAIN
    INNIS, RB
    CORREA, FMA
    UHL, GR
    SCHNEIDER, B
    SNYDER, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (01) : 521 - 525
  • [17] INTERACTION OF CCK WITH PANCREATIC ACINAR-CELLS
    JENSEN, RT
    WANK, SA
    ROWLEY, WH
    SATO, S
    GARDNER, JD
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (10) : 418 - 423
  • [18] KELLY JS, 1981, NEUROSECRETION BRAIN, P133
  • [19] EXPRESSION CLONING AND CHARACTERIZATION OF THE CANINE PARIETAL-CELL GASTRIN RECEPTOR
    KOPIN, AS
    LEE, YM
    MCBRIDE, EW
    MILLER, LJ
    LU, M
    LIN, HY
    KOLAKOWSKI, LF
    BEINBORN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) : 3605 - 3609
  • [20] KUWAHARA T, 1992, EUR J PHARMACOL, V221, P99